The "Episodic Ataxia Type 2 Hotspot Test" is a specialized genetic screening designed to identify mutations associated with Episodic Ataxia Type 2 (EA2), a rare, inherited neurological disorder characterized by episodes of ataxia (lack of muscle coordination), vertigo, and sometimes migraine headaches. EA2 is primarily caused by mutations in the CACNA1A gene, which plays a crucial role in the communication between neurons in the brain.
This test focuses on specific regions, or "hotspots," within the CACNA1A gene that are most commonly associated with the disorder, offering a targeted approach to genetic testing. By analyzing these hotspots, the test can provide crucial information for the diagnosis, management, and treatment planning for individuals showing symptoms of EA2 or those with a family history of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy, confidentiality, and professional analysis. The cost of the Episodic Ataxia Type 2 Hotspot Test is set at 1990 AED, reflecting the specialized nature of the test and the sophisticated technology employed in its execution.
For families and individuals facing the challenges of EA2, this test represents a valuable tool in understanding their genetic background and making informed health decisions.
The Multiple Myeloma Monitoring Panel Test is a comprehensive diagnostic tool designed to assess and monitor the progression or remission of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This specialized test panel includes a variety of assays that evaluate key markers and factors related to the disease, such as monoclonal protein levels, bone marrow function, and other relevant blood cell counts. It is crucial for tailoring patient treatment plans and tracking the effectiveness of therapy over time.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test offers precise and reliable results. The cost of the Multiple Myeloma Monitoring Panel Test is set at 1990 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and confidentiality of test results. This test is an essential resource for healthcare providers managing patients with multiple myeloma, offering critical insights that guide treatment decisions and improve patient outcomes.
The "ALL Panel Deletion/Duplication Detection Test" is a specialized genetic test offered by DNA Labs UAE, designed to identify deletions or duplications in the genome that are associated with Acute Lymphoblastic Leukemia (ALL). This advanced diagnostic tool is crucial for understanding the genetic basis of ALL and can provide valuable information for tailoring patient-specific treatment strategies. The test employs cutting-edge technology to scan the genome for abnormalities that could influence the course of the disease or impact the effectiveness of certain treatments. Priced at 1990 AED, this test represents a significant step forward in personalized medicine, offering hope for more effective management of ALL through targeted therapy options.
The AML PCR Panel AMLETO Inv16 PMLRARA Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect specific genetic mutations associated with Acute Myeloid Leukemia (AML). This test specifically targets the Inv16 (CBFB-MYH11) and PML-RARA gene rearrangements, which are critical markers for diagnosing certain subtypes of AML. Utilizing Polymerase Chain Reaction (PCR) technology, this panel provides a highly sensitive and accurate method for identifying these genetic abnormalities, which can play a crucial role in determining the most effective treatment plan for patients.
The cost of the AML PCR Panel AMLETO Inv16 PMLRARA Test at DNA Labs UAE is 1650 AED. This investment in testing is vital for patients suspected of having AML, as it aids in the quick and precise identification of their disease subtype, facilitating targeted therapy and improving treatment outcomes. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring that patients receive reliable and high-quality diagnostic services.
A Biopsy Breast Modified Radical Mastectomy is a comprehensive surgical procedure aimed at treating breast cancer by removing the entire breast along with the lymph nodes in the axilla (underarm area), while preserving the pectoral muscles. This operation is often recommended when the cancer is too extensive for a lumpectomy (removal of the tumor and a small margin of surrounding tissue) but where the preservation of the chest muscles is still possible, helping to maintain a better post-surgical cosmetic outcome and potentially reducing recovery time.
Following the surgical procedure, the extracted tissue is typically analyzed to assess the presence and extent of cancer. This is where tests such as ER (Estrogen Receptor), PR (Progesterone Receptor), and HER2/neu come into play. These tests are crucial in determining the cancer's characteristics, including its responsiveness to hormonal therapies and targeted treatments.
- **ER and PR Tests:** These tests measure the presence of estrogen and progesterone receptors in the cancer tissue. Cancers that are positive for these receptors (ER+ or PR+) are likely to respond to hormonal therapies, which can be an effective part of the treatment plan.
- **HER2/neu Test:** This test identifies the presence of the HER2 protein on the surface of the cancer cells. HER2-positive cancers are more aggressive but may respond well to targeted therapies designed to inhibit the HER2 protein.
At DNA Labs UAE, the cost for conducting the ER, PR, HER2/neu tests is 1650 AED. These tests are crucial for tailoring the most effective treatment plan post-mastectomy, offering a personalized approach to breast cancer care. DNA Labs UAE is equipped with state-of-the-art facilities and experienced professionals to ensure accurate and reliable test results, aiding in the optimal management and treatment of breast cancer.
DiGeorge Syndrome, also known as 22q11.2 deletion syndrome, is a disorder caused by a defect in chromosome 22, which results in poor development of several bodily systems. This genetic condition can lead to a range of health issues, including heart defects, immune system problems, facial anomalies, and developmental delays. Early detection and intervention are crucial for managing the symptoms and improving the quality of life for those affected.
To diagnose DiGeorge Syndrome, two main genetic tests are employed: Karyotyping and Fluorescence In Situ Hybridization (FISH) test. Karyotyping is a laboratory procedure that provides a comprehensive view of an individual's chromosomes to identify any large-scale genetic abnormalities, including the deletion characteristic of DiGeorge Syndrome. However, because the deletion in chromosome 22 that causes DiGeorge Syndrome can be very small, a more precise test, known as the FISH test, is often used to confirm the diagnosis. The FISH test is a molecular cytogenetic technique that uses fluorescent probes to visualize specific parts of chromosomes, allowing for the detection of the microdeletion on chromosome 22 associated with the syndrome.
In the UAE, DNA Labs offers these crucial genetic tests for diagnosing DiGeorge Syndrome. The cost of undergoing the testing process is 1650 AED. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accurate and reliable results, providing essential information for the management and treatment of individuals with DiGeorge Syndrome.
The "Large Biopsy 6- Amputation Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze tissue samples from larger areas that may require amputation. This test is crucial in diagnosing and understanding the extent of various conditions, including cancerous growths, infections, or other diseases that affect limbs or other large body parts, necessitating a detailed examination to guide treatment decisions, such as amputation. The procedure involves the removal of a significant tissue sample from the affected area, which is then meticulously analyzed in the laboratory for pathological assessment. DNA Labs UAE, known for its state-of-the-art facilities and expert team, offers this comprehensive test for a cost of 1650 AED, ensuring accurate and timely diagnosis to facilitate appropriate medical interventions.
Prader-Willi Syndrome (PWS) is a rare genetic disorder characterized by a variety of symptoms, including reduced muscle tone, feeding difficulties in early infancy, rapid weight gain and obesity in later childhood, developmental delays, and behavioral problems. It is caused by the loss of function of genes in a specific region of chromosome 15 (15q11-q13). To diagnose PWS, genetic testing is crucial, and among the methods used, karyotyping and Fluorescence In Situ Hybridization (FISH) are prominent.
Karyotyping is a test that allows scientists to examine the chromosomal makeup of an individual by looking at the size, shape, and number of chromosomes. It's useful in identifying large-scale genetic abnormalities, including the presence or absence of chromosomes that can lead to syndromes like PWS.
FISH test, on the other hand, is more precise and can pinpoint deletions or rearrangements in specific chromosome regions. For PWS, the FISH test targets the critical region on chromosome 15 to check for the specific deletion responsible for the syndrome. It uses fluorescent probes that bind to that region of the chromosome, allowing for the visualization of any genetic anomalies under a fluorescence microscope.
In the UAE, DNA Labs offers comprehensive genetic testing for Prader-Willi Syndrome, including both karyotyping and FISH tests. The cost for this combined testing is set at 1650 AED. Conducted in a state-of-the-art laboratory by skilled geneticists and technicians, these tests provide accurate diagnosis and are crucial for the management and treatment planning for individuals with PWS. Early diagnosis through these genetic tests can significantly impact the quality of life for those affected by the syndrome, offering them a chance for timely interventions and support.
William's Syndrome is a rare genetic disorder characterized by distinctive facial features, heart problems, developmental delays, and a unique personality profile that often includes a friendly and outgoing demeanor. The condition results from a deletion of genetic material on chromosome 7, which includes the elastin gene, critical for the development of blood vessels and other tissues.
Karyotyping and FISH (Fluorescence In Situ Hybridization) are two key diagnostic tests used to detect Williams Syndrome. Karyotyping involves arranging and photographing the chromosomes in a cell to detect any genetic abnormalities, including the deletion seen in Williams Syndrome. However, because the deletion is often too small to be seen on a standard karyotype, the FISH test is more commonly used for a definitive diagnosis. FISH uses fluorescent probes that bind to specific parts of chromosomes. In the case of Williams Syndrome, the FISH test targets the elastin gene on chromosome 7. If the probe does not bind, indicating the absence of the elastin gene, it confirms the diagnosis of Williams Syndrome.
At DNA Labs UAE, these tests are conducted with precision and care, providing reliable results for those seeking a diagnosis. The cost of the test is 1650 AED, a valuable investment for families seeking answers to their loved one's unique set of symptoms. Early diagnosis through these tests can lead to better management of the condition, including addressing cardiovascular issues, developmental delays, and providing the necessary support and interventions.
The FISH - ALK-1 Breakapart Rearrangement Test is a diagnostic procedure used to identify rearrangements involving the ALK gene, which can be critical in the diagnosis and treatment of certain types of cancer, such as non-small cell lung cancer (NSCLC). This test utilizes Fluorescence In Situ Hybridization (FISH) technology, a powerful technique that allows for the visualization of specific genetic abnormalities within individual cells. By detecting ALK rearrangements, healthcare providers can determine the most effective treatment plans for their patients, including the possibility of using ALK inhibitors, which have shown significant success in treating tumors with these genetic alterations.
Performed at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the FISH - ALK-1 Breakapart Rearrangement Test is available for a cost of 2080 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by highly skilled professionals, ensuring accurate and reliable test results. This test represents a crucial step in the personalized treatment of cancer, offering hope for improved outcomes through targeted therapy.
